Clinical Trials Interview June 2022, page-4

Does anyone recall the specific dates/year when elancos patents begin expiring on MPL?

I still wonder if the ever ongoing dog trialling is a method to not only gain more concrete evidence, but to stall until the patents run out. Despite them saying they would be happy to do a deal, it's never a preference.

This is the Rose coloured glasses view, a strategic smart decision. The other view is we are on the never ending PAA spin merry go round.

While I overall like the video, I was surprised and dissapointed to hear Roger say they are now in the early stages of engaging pharmas for the canine component....seriously Roger...you said this exact thing years ago when the elanco deal crumbled. Frankly I'm tired of hearing this same statement.

anyway lots on the horizon, we will all be hear another 12 to 24 months before we see some worthwhile returns imo.